A Study to Evaluate Efficacy, Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of a Single Dose of LEO 158968

Clinical trial NCT06444867 · COMPLETED

Trial details

NCT number: NCT06444867
Sponsor: LEO Pharma
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Joint Pain Gout Flares Joint Inflammation

Start date: 2025-01-07
Primary completion: 2025-09-18
Enrollment: 6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.